AlbertKheradpourMD

Pediatric Hematology & Oncology • San Bernardino, CA

Assistant Professor, Pediatrics, Loma Linda University School of Medicine

Join to view full profile

Dr. Kheradpour is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Kheradpour's full profile

Already have an account?

Office
250 E Caroline St
Ste J
San Bernardino, CA 92408
Phone+1 909-558-4800

Fax+1 909-651-1933
Is this information wrong?

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1991 - 1994
Atlantic Health System/Goryeb Children's HospitalResidency, Pediatrics, 1989 - 1991
Icahn School of Medicine at Mount Sinai (Jersey City)Internship, Pediatrics, 1988 - 1989
Tehran University of Medical Sciences School of MedicineClass of 1980

Certifications & Licensure

CA State Medical License 1992 - 2024
TX State Medical License 1995 - 1999
NJ State Medical License 1989 - 1999
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma Start of enrollment: 2013 Jan 31
Completed
Phase 1, Phase 2
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Start of enrollment: 2014 Jul 11
Active, not recruiting
Phase 2, Phase 3
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia Start of enrollment: 2019 Jul 03
Recruiting
Phase 3
Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia Start of enrollment: 2020 Apr 06
Active, not recruiting
Phase 1, Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients.
Lasky, J., Mullen, C., Angelucci, E., Vinti, L., Pemmaraju, N., Cuglievan, B., Kheradpour, A., Hijiya, N., Stein, A., Meshinchi, S., Mughal, T., Pawlowska, A.> ;Ejhaem. 2024 Feb 1
Epstein-Barr virus-associated lymphoproliferative disorder in a young child treated for Wilms tumor.
R. Aaron Robison, Shino Magaki, Albert Kheradpour, Sheri L. Harder, Jun Wang, David Yau, Craig W. Zuppan, Jeremy K. Deisch> ;Pediatric Hematology and Oncology. 2020 Jun 8
3 citations
Plasma Cell Myeloma Type Posttransplant Lymphoproliferative Disorder in an 18-Month-Old Heart Transplant Recipient: Case Report and Review of the Literature.
Lijun Xue, Craig W. Zuppan, Tiannan Wang, Albert Kheradpour, Edward H. Rowsell, Jun Wang> ;Journal of Pediatric Hematology/oncology. 2020 Apr 1
4 citations
Benign Giant Cell Lesion of C1 Lateral Mass: A Case Report and Literature Review.
Christopher Heinrich, Vadim Gospodarev, Albert Kheradpour, Craig W. Zuppan, Clifford C. Douglas, Tanya Minasian> ;Brain Sciences. 2019 May 8
3 citations
Spontaneous Regression of Diffuse Periosteal Melanotic Neuroectodermal Tumor of Infancy in the Tibia, With 13-Year Follow-up.
Li Lei, Brandon D. Ellsworth, Lionel W. Young, Albert Kheradpour, Craig W. Zuppan> ;Journal of Pediatric Hematology/oncology. 2019 Mar 1
17 citations
Response to Lenvatinib in Children with Papillary Thyroid Carcinoma.
Priya Mahajan, Jonathan Dawrant, Albert Kheradpour, Norma M. Quintanilla, Monica E. Lopez, Robert C. Orth, Ioanna D. Athanassaki, Rajkumar Venkatramani> ;Thyroid. 2018 Nov 12
23 citations
Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal F...
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Biology of Blood and Marrow Transplantation. 2018 Oct 1
1 citations
Cytotoxic Molecule-positive Epstein-Barr Virus-associated Peripheral T-cell Lymphoma in a 20-Month-old Child: A Case Report and Review of the Literature.
Huina Zhang, Albert Kheradpour, Edward H. Rowsell, Craig W. Zuppan, Lawrence M. Weiss, Jun Wang> ;Journal of Pediatric Hematology/oncology. 2015 Nov 1
11 citations
Mast cell sarcoma in an infant: a case report and review of the literature.
Marnelli A. Bautista-Quach, Cassie L. Booth, Albert Kheradpour, Craig W. Zuppan, Edward H. Rowsell, Lawrence M. Weiss, Jun Wang> ;Journal of Pediatric Hematology/oncology. 2013 May 1
22 citations
Quantitative correlation between promoter methylation and messenger RNA levels of the reduced folate carrier
Rui Yang, Wei Wei Li, Bang H. Hoang, Han-Soo Kim, Debabrata Banerjee, Albert Kheradpour, John H. Healey, Paul A. Meyers, Joseph R. Bertino, Richard Gorlick> ;BMC Cancer. 2008 May 1
105 citations
Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated...
Erdem Goker, Mark Waltham, A Kheradpour, Tanya M. Trippett, Madhu Mazumdar, Y Elisseyeff, Barbara Schnieders, Peter G. Steinherz, Cuiwen Tan, Ellin Berman> ;Blood. 1995 Jul 15
26 citations
Selective treatment of SCID mice bearing methotrexate-transport-resistant human acute lymphoblastic leukemia tumors with trimetrexate and leucovorin protection.
João F. Lacerda, Erdem Goker, A Kheradpour, Dieter Dennig, Y Elisseyeff, Catherine Jagiello, Richard J. O'Reilly, Joseph R. Bertino> ;Blood. 1995 May 15
8 citations
A Phase II Study of Continuous Infusion of Trimetrexate in Patients with Refractory Acute Leukemia
A Kheradpour, Ellin Berman, Erdem Goker, James T. Lin, William P. Tong, Joseph R. Bertino> ;Cancer Investigation. 1995 Jan 1
20 citations
Acute monocytic leukemia: a myeloid leukemia subset that may be sensitive to methotrexate.
Erdem Goker, A Kheradpour, Mark Waltham, Debabrata Banerjee, William P. Tong, Y Elisseyeff, Joseph R. Bertino> ;Leukemia. 1995 Jan 1
11 citations
Pharmacologic-guided trial of sequential methotrexate and thioguanine in children with advanced malignancies
Cuiwen Tan, N Wollner, Tanya M. Trippett, Erdem Goker, William P. Tong, A Kheradpour, Paul A. Meyers, K M VanSyckle, L Guarino, Y Elisseyeff> ;Journal of Clinical Oncology. 1994 Sep 1
Severe Hb S-beta+ thalassemia caused by IVS-I splice site mutations.
Li, J., Plonczynski, M., Steinberg, M. H., Kheradpour, A., Alter, B. P.> ;Hemoglobin. 1998 Jul
Join now to see all

Hospital Affiliations

Loma Linda University Medical CenterLoma Linda, California